+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Alopecia Market Size, Share & Trends Analysis Report By Treatment (Pharmaceuticals, Devices), By Disease Type (Alopecia Areata), By End-use, By Sales Channel, By Gender, By Country, And Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 150 Pages
  • June 2023
  • Region: North America
  • Grand View Research
  • ID: 5846780
Description Jump to:
The North America alopecia market size is expected to reach USD 5.65 billion by 2030, expanding at a 7.5% CAGR from 2023 to 2030, according to this report. The market is expected to be collectively driven by technological advancements in treatments, and the rise in the prevalence of diseases associated with hair loss. Moreover, various strategic initiatives undertaken by leading players such as the development of light-based treatment and other pharmaceutical products developments are also anticipated to propel growth forward during the projected period.

The competitive rivalry in North America alopecia industry is likely to remain high due to the presence of prominent market participants. Generic copies of branded drugs further intensify commercial competition. Key players are involved in the development of novel therapies or drugs, to target people with unmet clinical needs. For instance, Cassiopea S.p.A. is engaged in the development of treatment for female androgenetic alopecia, as there is no drug approved for this particular indication.

Organizations, such as National Alopecia Areata Foundation (NAAF), Canadian Alopecia Areata Foundation, and Cicatricial Alopecia Research Foundation, among others, promote funding to support R&D and product development exercises pertaining to the treatment. For instance, National Alopecia Areata Foundation (NAAF) provides research grants and funding to researchers. To date, the organization has provided 208 research grants, totaling around USD 5.7 million, to sponsor studies on the pathophysiology of diseases, immune pathways, and developing targeted treatments.

Moreover, ongoing funding programs by leading organizations to decrease the gaps in hair disorders research is likely to expedite market expansion. For instance, in April 2021, the American Academy of Dermatology Association announced the launch of the Hair Loss and Alopecia Initiative in Research (HAIR) funding program. Under this HAIR program funding will be offered to researchers, trainees, and dermatologists in the U.S. for completing research projects for the development of novel solutions for hair disorders.

Furthermore, regulatory approvals and various strategic initiatives undertaken by leading players are expected to propel growth forward. For instance, in June 2022, Incyte and Eli Lilly and Company announced that OLUMIANT (baricitinib) received approval from the U.S. FDA for systemic treatment for adults with severe AA. OLUMIANT pill is available in 1 mg, 2 mg, and 4 mg tablets. In addition, in April 2020 Aytu BioScience, Inc. announced the launch of OTC foam formulation of minoxidil for men and women. This product is indicated for reversing hair loss and is available through the company’s wholly-owned subsidiary Innovus Pharmaceuticals.

North America Alopecia Market Report Highlights

  • By treatment, the pharmaceutical segment held the largest share of the North America alopecia industry due to the widespread availability of pharmaceutical products, and the presence of novel therapeutics
  • The alopecia universalis segment is expected to register the highest CAGR rate in disease type segment owing to increasing awareness about severe forms of AA
  • By end-use, the dermatology clinics segment held the largest share of the North America alopecia industry in 2022 owing to the availability of modern treatment methods such as laser technology and increasing visits to doctors & dermatologists
  • The male gender segment held the largest share in 2022, whereas, the female gender segment is expected to register the highest CAGR rate during the forecast period
  • Some of the key market players include Pfizer Inc; Eli Lilly and Company; Merck & Co., Inc; Concert Pharmaceuticals; Curallux, LLC; PureTech; Freedom Laser Therapy, Inc; LUTRONIC; HCW Biologics Inc; Curallux, LLC; and others.


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation And Scope
1.1.1 Segment Definition
1.1.2 Segment & Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List Of Secondary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3.Competitive Landscape Snapshot
Chapter 3 North America Alopecia Market Variables, Trends, and Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration And Growth Prospect Mapping
3.3 Regulatory Landscape
3.4 Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Increasing Prevalence Of Alopecia
3.4.1.2 Increasing Healthcare Expenditure
3.4.1.3 Increasing Prevalence Of Chronic Diseases
3.4.1.4 Technological Advancements In Alopecia Treatment
3.4.2 Market Restraint Analysis
3.4.2.1 Lack Of Reimbursement Policies For Alopecia Treatment
3.4.2.2 Increasing Adoption Of Substitutes
3.5 Alopecia: Market Analysis Tools
3.5.1 Industry Analysis - Porter’s - (Pharmaceuticals)
3.5.2 Industry Analysis - Porter’s (Devices)
3.5.3 Swot Analysis, By Factor (Political & Legal, Economic And Technological) (Pharmaceuticals)
3.5.4 Swot Analysis, By Factor (Political & Legal, Economic And Technological) (Devices)
3.6 Pipeline Analysis
Chapter 4 North America Alopecia Market: Segment Analysis, By Disease Type, 2018 - 2030 (USD Million)
4.1 North America Alopecia Market: Disease Type Movement Analysis
4.1.1 Market Size & Forecasts And Trend Analyses, 2018 To 2030
4.1.2 Alopecia Areata
4.1.2.1 Alopecia Areata Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.2.2 Male Alopecia Areata Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.2.3 Female Alopecia Areata Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.3 Cicatricial Alopecia
4.1.3.1 Cicatricial Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.3.2 Male Cicatricial Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.3.3 Female Cicatricial Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.4 Traction Alopecia
4.1.4.1 Traction Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.4.2 Male Traction Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.4.3 Female Traction Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.5 Alopecia Totalis
4.1.5.1 List Of Organizations
4.1.5.2 Alopecia Totalis Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.5.3 Male Alopecia Totalis Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.5.4 Female Alopecia Totalis Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.6 Alopecia Universalis
4.1.6.1 Alopecia Universalis Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.6.2 Male Alopecia Universalis Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.6.3 Female Alopecia Universalis Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.7 Androgenetic Alopecia
4.1.7.1 Androgenetic alopecia market estimates and forecast, 2018 - 2030 (USD Million)
4.1.7.2 Male androgenetic alopecia market estimates and forecast, 2018 - 2030 (USD Million)
4.1.7.3 Female androgenetic alopecia market estimates and forecast, 2018 - 2030 (USD Million)
4.1.8 OTHERS
4.1.8.1 Other alopecia market estimates and forecast, 2018 - 2030 (USD Million)
4.1.8.2 Male other alopecia market estimates and forecast, 2018 - 2030 (USD Million)
4.1.8.3 Female other alopecia market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 5 North America Alopecia Market: Segment Analysis, By Treatment, 2018 - 2030 (USD Million)
5.1 North America Alopecia Market: Treatment Movement Analysis
5.2 Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.2.1 Pharmaceuticals
5.2.1.1 Pharmaceuticals Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.1.2 Topical Drugs
5.2.1.2.1 Topical Drugs Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.1.2.2 Topical Otc Drugs
5.2.1.2.2.1 Topical Otc Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.1.2.2.2 Minoxidil
5.2.1.2.2.2.1 Minoxidil Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.1.2.2.3 Other Otc Drugs
5.2.1.2.2.3.1 Other Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.1.2.3 Topical Prescription Drugs
5.2.1.2.3.1 Topical Prescription Drugs Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.1.2.3.2 Betamethasone Dipropionate
5.2.1.2.3.2.1 Betamethasone Dipropionate Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.1.2.3.3 Fluocinolone Acetonide
5.2.1.2.3.3.1 Fluocinolone Acetonide Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.1.2.3.4 Finasteride
5.2.1.2.3.4.1 Finasteride Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.1.2.3.5 Minoxidil
5.2.1.2.3.5.1 Minoxidil Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.1.3 Oral Drugs
5.2.1.3.1 Oral Drugs Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.1.3.2 Oral Otc Drugs
5.2.1.3.2.1 Oral Otc Drugs Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.1.3.3 Oral Prescription Drugs
5.2.1.3.3.1 Oral Prescription Drugs Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.1.3.3.2 Minoxidil
5.2.1.3.3.2.1 Minoxidil Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.1.3.3.3 Finasteride
5.2.1.3.3.3.1 Finasteride Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.1.3.3.4 Oral Corticosteroids
5.2.1.3.3.4.1 Oral Corticosteroids Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.1.4 Platelet - Rich Plasma Injections
5.2.1.4.1 Platelet - Rich Plasma Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.2 Devices
5.2.2.1 Devices Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.2.2 Laser Cap
5.2.2.2.1 Laser Cap Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.2.3 Laser Comb
5.2.2.3.1 Laser Comb Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.2.4 Laser Helmet
5.2.2.4.1 Laser Helmet Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 6 North America Alopecia Market: Segment Analysis, By Gender, 2018 - 2030 (USD Million)
6.1 North America Alopecia Market: Gender Movement Analysis
6.2 Market Size & Forecasts And Trend Analyses, 2018 To 2030
6.2.1 Male
6.2.1.1 Male Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2 Female
6.2.2.1 Female Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 7 North America Alopecia Market: Segment Analysis, By End - Use, 2018 - 2030 (USD Million)
7.1 North America Alopecia Market: End - Use Movement Analysis
7.2 Market Size & Forecasts And Trend Analyses, 2018 To 2030
7.2.1 Homecare Settings
7.2.1.1 Homecare Settings Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.2 Dermatology Clinics
7.2.2.1 Dermatology Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 8 North America Alopecia Market: Segment Analysis, By Region, 2018 - 2030 (USD Million) (Number Of Patients, In Thousands)
8.1 Alopecia Market: Country Movement Analysis
8.2 Regional Market Share Analysis, 2022 & 2030
8.3 Market Size, & Forecasts, Revenue And Trend Analysis, 2018 To 2030
8.3.1 North America
8.3.1.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.1.2 U.S.
8.3.1.2.1 U.S. Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.1.3 Canada
8.3.1.3.1 Canada Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 9 North America Alopecia Market: Competitive Analysis (Pharmaceuticals)
9.1 Recent Developments And Impact Analysis, By Key Market Participants
9.1.1 New Product Launches
9.1.2 Mergers And Acquisitions
9.1.3 Joint Venture
9.1.4 Partnerships And Licensing Agreements
9.1.5 Conferences And Campaigns
9.2 Company Categorization
9.2.1 Innovators
9.2.2 Market Leaders
9.2.3 Heat Map Analysis
9.3 Vendor Landscape
9.3.1 List Of Key Distributors And Channel Partners
9.3.2 Key Customers
9.4 Public Companies
9.4.1 Key Company Market Share Analysis, 2022
9.4.2 Company Market Position Analysis
9.4.3 Competitive Dashboard Analysis
9.4.3.1 Market Differentiators
9.5 Private Companies
9.5.1 List Of Key Emerging Companies
9.6 Company Profiles (Pharmaceuticals)
9.6.1 CIPLA LIMITED
9.6.1.1 Company overview
9.6.1.2 Financial Performance
9.6.1.3 Product benchmarking
9.6.2 SUN PHARMACEUTICALS INDUSTRIES LTD.
9.6.2.1 Company overview
9.6.2.2 Financial Performance
9.6.2.3 Product benchmarking
9.6.2.4 Strategic initiatives
9.6.3 JOHNSON & JOHNSON SERVICES, INC.
9.6.3.1 Company overview
9.6.3.2 Financial Performance
9.6.3.3 Product benchmarking
9.6.3.4 Strategic initiatives
9.6.4 MERCK & CO., INC.
9.6.4.1 Company overview
9.6.4.2 Financial Performance
9.6.4.3 Product benchmarking
9.6.4.4 Strategic initiatives
9.6.5 LEXINGTON INTL., LLC
9.6.5.1 Company overview
9.6.5.2 Product benchmarking
9.6.6 CIRRUS HAIR CENTERS
9.6.6.1 Company overview
9.6.6.2 Financial Performance
9.6.6.3 Product benchmarking
9.6.7 VITA - COS - MED KLETT - LOCH GMBH
9.6.7.1 Company overview
9.6.7.2 Product benchmarking
9.6.8 TRANSITIONS HAIR
9.6.8.1 Company overview
9.6.8.2 Product benchmarking
9.6.9 PURETECH HEALTH
9.6.9.1 FOLLICA, INC.
9.6.9.1.1 Company overview
9.6.9.2 Financial Performance
9.6.9.3 Product benchmarking
9.6.9.4 Strategic initiatives
9.6.10 CURALLUX, LLC
9.6.10.1 Company overview
9.6.10.2 Product benchmarking
9.6.10.3 Strategic initiatives
9.6.11 DR. REDDY'S LABORATORIES LTD
9.6.11.1 Company overview
9.6.11.2 Financial Performance
9.6.11.3 Product benchmarking
9.6.11.4 Strategic initiatives
9.6.12 GLAXOSMITHKLINE PLC (GSK)
9.6.12.1 Company overview
9.6.12.2 Financial Performance
9.6.12.3 Product benchmarking
9.6.13 AUROBINDO PHARMA
9.6.13.1 Company overview
9.6.13.2 Financial Performance
9.6.13.3 Product benchmarking
9.6.14 MYLAN N.V. (VIATRIS, INC.)
9.6.14.1 Company overview
9.6.14.2 Financial Performance
9.6.14.3 Product benchmarking
9.6.14.4 Strategic initiatives
Chapter 10 North America Alopecia Market: Competitive Analysis (Devices)
10.1 Recent Developments and Impact Analysis, by Key Market Participants
10.1.1 Major Deals And Strategic Alliances Analysis
10.1.1.1 New Product Launches
10.1.1.2 Partnerships and Licensing Agreements
10.1.1.3 Conferences and Campaigns
10.2 Company Categorization
10.2.1 Innovators
10.2.2 Market Leaders
10.2.3 Heat Map Analysis
10.3 Vendor Landscape
10.3.1 List Of Key Distributors And Channel Partners
10.3.2 Key Customers
10.4 Public Companies
10.4.1 Competitive Dashboard Analysis
10.4.1.1 Market Differentiators
10.4.2 Company Market Share Analysis (Devices), 2022
10.5 Private Companies
10.5.1 List Of Key Emerging Companies
10.6 Company Profiles (Devices)
10.6.1 FREEDOM LASER THERAPY, INC.
10.6.1.1 Company overview
10.6.1.2 Product benchmarking
10.6.1.3 Strategic initiatives
10.6.2 APIRA SCIENCE, INC. (IGROW LASER.)
10.6.2.1 Company overview
10.6.2.2 Product benchmarking
10.6.2.3 Strategic initiatives
10.6.3 REVIAN, INC
10.6.3.1 Company overview
10.6.3.2 Product benchmarking
10.6.3.3 Strategic initiatives
10.6.4 THERADOME INC.
10.6.4.1 Company overview
10.6.4.2 Product benchmarking
10.6.4.3 Strategic initiatives
10.6.5 LUTRONIC INC.
10.6.5.1 Company overview
10.6.5.2 Product benchmarking
10.6.5.3 Strategic initiatives
10.6.6 WON TECH CO., LTD
10.6.6.1 Company overview
10.6.6.2 Product benchmarking
10.6.6.3 Strategic initiatives
10.6.7 LIFEMD
10.6.7.1 Company overview
10.6.7.2 Product benchmarking
10.6.7.3 Strategic initiatives
10.6.8 LG ELECTRONICS
10.6.8.1 Company overview
10.6.8.2 Product benchmarking
10.6.8.3 Strategic initiatives
List of Tables
Table 1: List of secondary sources
Table 2: List of abbreviations
Table 3: Regulatory framework
Table 4: List of late-stage clinical trials
Table 5: Approved generic version of Avodart:
Table 6: Androgenetic alopecia in men and women
Table 7: List of parameters
Table 8: Leading market players anticipated to witness highest growth
Table 9: List of key distributors
Table 10: Key company market share (%)
Table 11: List of parameters
Table 12: Leading market players anticipated to witness highest growth
Table 13: List of other distributors
Table 14: Key company market share (%)
Table 15: North America Alopecia Market, By Country, 2018-2030 (USD Million)
Table 16: North America Alopecia Market, By Treatment, 2018-2030 (USD Million)
Table 17: North America Alopecia Market, By Disease Type, 2018-2030 (USD Million)
Table 18: North America Alopecia Market, By End-Use, 2018-2030 (USD Million)
Table 19: North America Alopecia Market, By Sales Channel, 2018-2030 (USD Million)
Table 20: North America Alopecia Market, By Gender, 2018-2030 (USD Million)
Table 21: U.S. Alopecia Market, By Treatment, 2018-2030 (USD Million)
Table 22: U.S. Alopecia Market, By Disease Type, 2018-2030 (USD Million)
Table 23: U.S. Alopecia Market, By End-Use, 2018-2030 (USD Million)
Table 24: U.S. Alopecia Market, By Sales Channel, 2018-2030 (USD Million)
Table 25: U.S. Alopecia Market, By Gender, 2018-2030 (USD Million)
Table 26: Canada Alopecia Market, By Treatment, 2018-2030 (USD Million)
Table 27: Canada Alopecia Market, By Disease Type, 2018-2030 (USD Million)
Table 28: Canada Alopecia Market, By End-Use, 2018-2030 (USD Million)
Table 29: Canada Alopecia Market, By Sales Channel, 2018-2030 (USD Million)
Table 30: Canada Alopecia Market, By Gender, 2018-2030 (USD Million)
List of Figures
Fig. 1: North America alopecia market segmentation
Fig. 2: Market research process
Fig. 3: Information procurement
Fig. 4: Primary research pattern
Fig. 5: Primary interviews, by type
Fig. 6: Primary interviews, by country
Fig. 7: Market research approaches
Fig. 8: Value - chain - based sizing & forecasting
Fig. 9: QFD modeling for market share assessment
Fig. 10: Market formulation & validation
Fig. 11: Market outlook (2022)
Fig. 12: Penetration & growth prospect mapping
Fig. 13: Market driver relevance analysis (Current & future impact)
Fig. 14: Market restraint relevance analysis (Current & future impact)
Fig. 15: Porter’s five forces analysis
Fig. 16: Porter’s five forces analysis, Devices
Fig. 17: SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 18: SWOT analysis, by factor (political & legal, economic, and technological), Devices
Fig. 19: North America alopecia market disease type outlook: Key takeaways
Fig. 20: North America alopecia market: Disease type movement analysis
Fig. 21: Alopecia areata market estimates and forecast, 2018-2030 (USD Million)
Fig. 22: Male alopecia areata market estimates and forecast, 2018-2030 (USD Million)
Fig. 23: Female alopecia areata market estimates and forecast, 2018-2030 (USD Million)
Fig. 24: Cicatricial alopecia market estimates and forecast, 2018-2030 (USD Million)
Fig. 25: Male cicatricial alopecia market estimates and forecast, 2018-2030 (USD Million)
Fig. 26: Female cicatricial alopecia market estimates and forecast, 2018-2030 (USD Million)
Fig. 27: Traction alopecia market estimates and forecast, 2018-2030 (USD Million)
Fig. 28: Male traction alopecia market estimates and forecast, 2018-2030 (USD Million)
Fig. 29: Female traction alopecia market estimates and forecast, 2018-2030 (USD Million)
Fig. 30: Alopecia totalis market estimates and forecast, 2018-2030 (USD Million)
Fig. 31: Male alopecia totalis market estimates and forecast, 2018-2030 (USD Million)
Fig. 32: Female alopecia totalis market estimates and forecast, 2018-2030 (USD Million)
Fig. 33: Alopecia universalis market estimates and forecast, 2018-2030 (USD Million)
Fig. 34: Male alopecia universalis market estimates and forecast, 2018-2030 (USD Million)
Fig. 35: Female alopecia universalis market estimates and forecast, 2018-2030 (USD Million)
Fig. 36: Androgenetic alopecia market estimates and forecast, 2018-2030 (USD Million)
Fig. 37: Male androgenetic alopecia market estimates and forecast, 2018-2030 (USD Million)
Fig. 38: Female androgenetic alopecia market estimates and forecast, 2018-2030 (USD Million)
Fig. 39: Other alopecia market estimates and forecast, 2018-2030 (USD Million)
Fig. 40: Male other alopecia market estimates and forecast, 2018-2030 (USD Million)
Fig. 41: Female other alopecia market estimates and forecast, 2018-2030 (USD Million)
Fig. 42: North America Alopecia market treatment outlook: Key Takeaways
Fig. 43: Alopecia market: Treatment movement analysis
Fig. 44: Pharmaceuticals market estimates and forecast, 2018-2030 (USD Million)
Fig. 45: Topical drugs market estimates and forecast, 2018-2030 (USD Million)
Fig. 46: Topical OTC market estimates and forecast, 2018-2030 (USD Million)
Fig. 47: Minoxidil market estimates and forecast, 2018-2030 (USD Million)
Fig. 48: Other market estimates and forecast, 2018-2030 (USD Million)
Fig. 49: Topical prescription drugs market estimates and forecast, 2018-2030 (USD Million)
Fig. 50: Betamethasone dipropionate market estimates and forecast, 2018-2030 (USD Million)
Fig. 51: Fluocinolone acetonide market estimates and forecast, 2018-2030 (USD Million)
Fig. 52: Finasteride market estimates and forecast, 2018-2030 (USD Million)
Fig. 53: Minoxidil market estimates and forecast, 2018-2030 (USD Million)
Fig. 54: Oral drugs market estimates and forecast, 2018-2030 (USD Million)
Fig. 55: Oral OTC drugs market estimates and forecast, 2018-2030 (USD Million)
Fig. 56: Oral prescription drugs market estimates and forecast, 2018-2030 (USD Million)
Fig. 57: Minoxidil market estimates and forecast, 2018-2030 (USD Million)
Fig. 58: Finasteride market estimates and forecast, 2018-2030 (USD Million)
Fig. 59: Oral corticosteroids market estimates and forecast, 2018-2030 (USD Million)
Fig. 60: Platelet - rich plasma market estimates and forecast, 2018-2030 (USD Million)
Fig. 61: Devices market estimates and forecast, 2018-2030 (USD Million)
Fig. 62: Laser cap market estimates and forecast, 2018-2030 (USD Million)
Fig. 63: Laser comb market estimates and forecast, 2018-2030 (USD Million)
Fig. 64: Laser helmet market estimates and forecast, 2018-2030 (USD Million)
Fig. 65: North America Alopecia market gender outlook: Key takeaways
Fig. 66: North America Alopecia market: Gender movement analysis
Fig. 67: Male market estimates and forecast, 2018-2030 (USD Million)
Fig. 68: Female market estimates and forecast, 2018-2030 (USD Million)
Fig. 69: North America Alopecia market end - use outlook: Key takeaways
Fig. 70: North America Alopecia market: end - use movement analysis
Fig. 71: Homecare settings market estimates and forecast, 2018-2030 (USD Million)
Fig. 72: Dermatology clinics market estimates and forecast, 2018-2030 (USD Million)
Fig. 73: North America Alopecia market sales channel outlook: Key takeaways
Fig. 74: North America Alopecia market: Sales channel movement analysis
Fig. 75: Prescriptions market estimates and forecast, 2018-2030 (USD Million)
Fig. 76: OTC market estimates and forecast, 2018-2030 (USD Million)
Fig. 77: Regional outlook, 2022 & 2030
Fig. 78: North America
Fig. 79: North America alopecia market estimates and forecast, 2018-2030 (USD Million) (Number of Patients, in Thousands)
Fig. 80: U.S.
Fig. 81: U.S. alopecia market estimates and forecast, 2018-2030 (USD Million) (Number of Patients, in Thousands)
Fig. 82: Canada
Fig. 83: Canada alopecia market estimates and forecast, 2018-2030 (USD Million) (Number of Patients, in Thousands)
Fig. 84: Heat map analysis
Fig. 85: Company market position analysis (2022)
Fig. 86: Company market position analysis (2022)
Fig. 87: Market differentiators
Fig. 88: Strategy mapping
Fig. 89: Heat map analysis
Fig. 90: Market differentiators

Companies Mentioned

  • FREEDOM LASER THERAPY, INC.
  • APIRA SCIENCE, INC. (IGROW LASER.)
  • REVIAN, INC
  • THERADOME INC.
  • LUTRONIC INC.
  • WON TECH CO., LTD
  • LIFEMD
  • LG ELECTRONICS

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedJune 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 2.88 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.65 Billion
Compound Annual Growth Rate7.5%
Regions CoveredNorth America
No. of Companies Mentioned8

Related Topics

Related Reports

Global Alopecia Market Size, Share & Trends Analysis Report by Disease Type (Alopecia Areata, Cicatricial, Traction, Androgenetic Alopecia), Treatment, Gender, Sales Channel, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Alopecia Market Size, Share & Trends Analysis Report by Disease Type (Alopecia Areata, Cicatricial, Traction, Androgenetic Alopecia), Treatment, Gender, Sales Channel, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From
Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Gender (Male, Female), By Treatment (Pharmaceuticals, Devices), By End-use (Dermatology Clinics, Homecare Settings), By Sales Channel, And Segment Forecasts, 2024 - 2030 - Product Image

Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Gender (Male, Female), By Treatment (Pharmaceuticals, Devices), By End-use (Dermatology Clinics, Homecare Settings), By Sales Channel, And Segment Forecasts, 2024 - 2030

  • Report
  • 150 Pages
  • Global
From
Global Alopecia Treatment Market by Disease Type (Alopecia Areata, Alopecia Totalis, Alopecia Universalis), Route of Administration (Injectable, Oral, Topical), Gender, Treatment Option, End User - Forecast 2024-2030 - Product Image

Global Alopecia Treatment Market by Disease Type (Alopecia Areata, Alopecia Totalis, Alopecia Universalis), Route of Administration (Injectable, Oral, Topical), Gender, Treatment Option, End User - Forecast 2024-2030

  • Report
  • 196 Pages
  • Global
From
Global Alopecia Drugs Market by Alopecia Types (Alopecia Areata, Alopecia Totalis, Alopecia Universalis), Gender (Men, Women), Route of Administration - Forecast 2024-2030 - Product Image

Global Alopecia Drugs Market by Alopecia Types (Alopecia Areata, Alopecia Totalis, Alopecia Universalis), Gender (Men, Women), Route of Administration - Forecast 2024-2030

  • Report
  • 187 Pages
  • Global
From
Alopecia Global Market Report 2024 - Product Image

Alopecia Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From

About the Alopecia Drug Market

The Alopecia Drug market is a subset of the Immune Disorders Drugs market, which focuses on treatments for autoimmune diseases. Alopecia is an autoimmune disorder that causes hair loss, and drugs used to treat it are designed to reduce inflammation and suppress the immune system. These drugs are typically administered orally or topically, and may include corticosteroids, immunosuppressants, and biologics. The Alopecia Drug market is highly competitive, with many companies developing treatments for the disorder. Some of the major players in the market include Pfizer, Novartis, Merck, Johnson & Johnson, and GlaxoSmithKline. Other companies, such as Sun Pharmaceuticals, Cipla, and Dr. Reddy's Laboratories, are also active in the market. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.